Daptomycin Breakpoints for Enterococci, 1st Edition
This rationale document describes revisions made to change minimal inhibitory concentration breakpoints and introduce new resistant and susceptible-dose dependent breakpoints supported by higher dosage treatment regimen options for daptomycin.
Chairholder: Romney M. Humphries, PhD, D(ABMM)
Date of Publication: September 19, 2019
Order Code PDF: MR06Ed1E
ISBN Number: 978-1-68440-058-4
Order Code Print: print not available